文献速递泌尿生殖腹部MR

治疗前定量多参数MRI可预测前列腺癌放疗后的生化结局

Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer?
PubMed 文献 · Acad Radiol · 2021-10-11

中位随访65个月后7例出现生化失败,ADC预测放疗结局的AUC为0.71,较低ADC与更差的生化控制相关,而T2和DCE参数与生化结局无关。

要点

  • 索引病灶ADC较低者放疗后生化失败风险更高,ADC可作为预测指标。
  • ADC预测生化失败的理想阈值为0.96 µm²/ms,敏感度100%但特异度仅48%。
  • 定量T2和DCE参数与放疗后生化结局无关,阅片时重点关注ADC。

核心结论

  • 索引病灶的定量ADC值可能预测前列腺癌患者接受根治性放疗后的生化失败,ADC较低者生化控制较差。

研究设计与样本

  • 由放射科医师勾画索引病灶并测量ADC、T2和DCE定量参数,生化失败采用Phoenix标准定义。

关键影像表现/征象

  • 生化失败组索引病灶ADC显著低于无失败组(0.78 ± 0.17 vs 0.96 ± 0.26 µm²/ms,p = 0.04)。
  • 定量T2和DCE参数与生化结局无关联。

诊断标准与关键数值

  • ADC预测放疗结局的ROC曲线下面积为0.71。
  • Youden指数确定的最佳ADC截断值为0.96 µm²/ms,预测生化失败的敏感度为100%、特异度为48%。
  • Kaplan-Meier分析显示较低ADC与显著更低的生化失败自由生存(FFBF)相关(p = 0.03);ADC ≥ 0.96 µm²/ms的20例中无失败,ADC < 0.96 µm²/ms的31例中7例失败。
  • 多因素分析中,校正NCCN风险分类(p = 0.064)和雄激素剥夺治疗(p = 0.141)后,ADC仍与FFBF相关(ADC每增加0.01 µm²/ms的HR为0.96 [95% CI, 0.92-1.00],p = 0.042)。

临床应用与阅片要点

  • 放疗前前列腺多参数MRI应测量索引病灶ADC,低ADC(< 0.96 µm²/ms)提示放疗后生化失败风险较高。
  • ADC截断值0.96 µm²/ms敏感度高达100%但特异度低(48%),需结合NCCN风险分类和是否接受雄激素剥夺治疗综合判断。
  • T2和DCE定量参数对预测放疗后生化结局价值有限,报告时可侧重ADC。

局限性

  • 单中心研究,放疗方案异质(外照射、近距离治疗及联合boost)。
  • ADC截断值特异度较低,预测价值需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To investigate whether pre-treatment quantitative multiparametric MRI can predict biochemical outcome of prostate cancer (PCa) patients treated with primary radiotherapy (RT).

MATERIALS AND METHODS: Fifty-one patients with biopsy confirmed PCa underwent prostate multiparametric MRI on 3T MR scanner prior to RT. Thirty-seven men (73%) were treated with external beam RT alone, 12 men (24%) were treated with brachytherapy monotherapy, and two men (4%) were treated with external beam RT with brachytherapy boost. The index lesion was outlined by a radiologist and quantitative apparent diffusion coefficient (ADC), T2 and DCE parameters were measured. Biochemical failure was defined using the Phoenix criteria.

RESULTS: After a median follow-up of 65 months, seven patients had biochemical failure. ADC had an area under the receiver operating characteristic curve of 0.71 for predicting RT outcome with significantly lower ADC (0.78 ± 0.17 vs 0.96 ± 0.26 µm2/ms, p = 0.04) of the index lesion in men with biochemical failure. Ideal ADC cutoff point (Youdens index) was 0.96 µm2/ms which had a sensitivity of 100% and specificity of 48% for predicting biochemical failure. Kaplan-Meier analysis showed that lower ADC values were associated with significantly lower freedom from biochemical failure (FFBF, p = 0.03, no failures out of 20 men if ADC ≥ 0.96 µm2/ms; seven of 31 with failures if ADC < 0.96 µm2/ms). On multivariable analysis, ADC was associated with FFBF (HR 0.96 per increase in ADC of 0.01 um2/ms [95% CI, 0.92-1.00]; p = 0.042) after accounting for National Comprehensive Cancer Network risk category (p = 0.064) and receipt of androgen deprivation therapy (p = 0.141). Quantitative T2 and DCE parameters were not associated with biochemical outcome.

CONCLUSION: Our results suggest that quantitative ADC values of the index lesion may predict biochemical failure following primary radiotherapy in patients with PCa. Lower ADC values were associated with inferior biochemical control.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Chatterjee A, Turchan WT, Fan X, et al. Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer? Acad Radiol. 2021. PMID: 34645572. doi:10.1016/j.acra.2021.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。